Collaterals: an Important Determinant of Prolonged Ischemic Penumbra versus Rapid Cerebral Infarction?
Intravenous tissue plasminogen activator is the mainstay for the treatment of acute ischemic stroke in patients presenting within 4.5 hours of symptom onset. Studies have demonstrated that treating patients early leads to improved long term outcomes. MR imaging currently allows quantification of the...
| 發表在: | Frontiers in Neurology |
|---|---|
| Main Authors: | , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Frontiers Media S.A.
2014-10-01
|
| 主題: | |
| 在線閱讀: | http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00208/full |
